
Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells.
With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.
Join Orano USA, where we're powering the future with innovation collaboration, and purpose. The Intern – Radiopharmaceutical Manufacturing will participate in the establishment of ATLab Indianapolis as a new commercial-scale manufacturing facility for therapeutic radiopharmaceuticals. The facility will be geared towards ramp up of activities to support Phase 3 clinical trials and commercial manufacturing. During Summer 2026, the facility will be concluding construction and qualification, so the Intern should focus efforts on: safety and occupational training, completing an assigned project, helping with basic tasks, growing in technical understanding, developing workplace skills, and building a professional network.
Key Responsibilities:
Safety and Compliance
Production, QC, Shipping
Quality Assurance
Project
Travel
Qualifications:
Why Join Orano?
At Orano, you’ll be more than “just an intern.” You’ll be part of a mission-driven team shaping the future of sustainable energy while gaining real-world HR experience. You’ll have the opportunity to innovate, contribute, and grow—personally and professionally—in an environment that values your voice.